Fred Alger Management, LLC Ocular Therapeutix, Inc Transaction History

Fred Alger Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $138,420 - $240,052	45,987 New	45,987 $185,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $655,564 - $969,154	-67,584 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $38,852 - $55,429	-2,893 Reduced 4.1%	67,584 $958,000
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $16,389 - $22,905	-1,036 Reduced 1.45%	70,477 $1.16 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $469,268 - $1.36 Million	-59,326 Reduced 45.34%	71,513 $1.48 Million
Q3 2020 Nov 13, 2020	SELL	$7.36 - $9.87 $67,424 - $90,419	-9,161 Reduced 6.54%	130,839 $996,000
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $490,350 - $939,749	105,000 Added 300.0%	140,000 $1.17 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $138,250 - $259,000	35,000 New	35,000 $173,000

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.